23 Hrs
Source:
وكالة مدار نيوز
AI-developed drug reverses aging signs
A new study has shown that the drug "Rentosirtipe," developed by InSilico Medicine using artificial intelligence, is associated with a temporary reduction in biological age indicators in patients with idiopathic pulmonary fibrosis. However, there is currently no conclusive evidence that it actually delays or reverses aging. The study, published in "Nature Biotechnology," was based on blood protein analysis of 42 patients out of 71. It indicated that some computational models suggest a decrease of 3 to 6 years in biological age after treatment, but the results are limited due to the small sample size and short follow-up duration. The researchers emphasized that these findings do not definitively prove the drug's effect on aging and cannot be generalized to healthy individuals or other populations. They stressed the need for larger, longer-term studies to establish any independent impact of the drug on the aging process.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)